Predictive Markers of Neurological Complications in Patients Treated With Extracorporeal Membrane Oxygenation

Adeel Abbasi¹, Linn Ayers¹, Ron Balczon¹+9

• ¹From the Department of Medicine (A. A., M. C., and C. E. V.), Division of Pulmonary, Critical Care & Sleep Medicine, Warren Alpert Medical School of Brown University; the Department of Physiology & Cell Biology (L. A., R. B., A. R. N., A. J. B., and T. S.), University of South Alabama; the Department of Medicine (L. A. and T. S.), the Center for Lung Biology (R. B. and T. S.), and the Gulf Coast Alzheimer's Disease Research Center (A. R. N. and A. J. B.), University of South Alabama College of Medicine; the University of Vermont Larner College of Medicine (N. A.); the Department of Respiratory Care (J. R. P.), Brown University Health; the Cardiovascular Institute, Department of Medicine (S. V.) and the Department of Diagnostic Imaging (G. L. B.), Warren Alpert Medical School of Brown University; and the Department of Health Services, Policy & Practice (C. E. V.), Brown School of Public Health.